Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 1;1(6):177-179.
doi: 10.1002/cld.117.

Molecular Epidemiology of Hepatocellular Carcinoma

Yujin Hoshida  1
Affiliations

Molecular Epidemiology of Hepatocellular Carcinoma

Yujin Hoshida. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multistep process of HCC development in chronic liver disease. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 2
Figure 2
Molecular subclasses of HCC. Abbreviation: TGF‐β, transforming growth factor‐β. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
See this image and copyright information in PMC

References

    1. El‐Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118‐1127. - PubMed
    1. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425‐436. - PubMed
    1. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El‐Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 2010;52:132‐141. - PMC - PubMed
    1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379:1245‐1255. - PubMed
    1. Hoshida Y, Fuchs BC, Tanabe KK. Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets. In press. - PMC - PubMed